先声药业递交注射用曲拉西利新药上市申请 系首个骨髓保护CDK4/6抑制剂

七印授权

53C5B003I793NSMUWP84EQ82M9MUCL8R7IGBV4TGSRR3C5MP49

2021-12-13 05:22:22

article

879055B50CDAEB710726410359A5DEE1807A709F0BE1792BDE34F144C289E628

zh-CN

7ECAEAACF51738AEB7C8867D8E1CEADECD0D2F4E

10882750

02636d79fc7c7cc37b9cb348037eec28743d030e5d570d0d69837a3587bed31880

6cbd5cdf1826df987d197acb88336399b26255d453dacfa0c23e4efd66ce4cbe0aaa8df980e344cb03d6f74eb02275eea8060a3eaed220b36a570902f6bdf7051b

{"parameters":{"adaptation":"n","authorized":"七印信息科技","price":"100000"},"type":"cm"}

yuanben_61b6d88ee58bf8.93190843

原本认证

603Y6X0WEMRO5Z7UGDQSYFYJIOTZ55499QLBHAL4Z13W85Y0OG

https://www.yuanben.io/article/48392118-dfab-40dd-a1bc-5f6d534b0b20

{"author":"每日经济新闻","authorization_pub_key":"03040cbbeae1adf91c3efd7306d09c6005403a041f9b7405dac489d4f8126fef8c"}